Publication:
Dramatic reduction of ventricular tachycardia burden after dronedarone plus mexiletine treatment in a patient refractory to hybrid ablation.

dc.contributor.authorFrutos-López, Manuel
dc.contributor.authorPedrote, Alonso
dc.contributor.authorAcosta-Martínez, Juan
dc.contributor.authorArana-Rueda, Eduardo
dc.date.accessioned2023-02-08T14:47:17Z
dc.date.available2023-02-08T14:47:17Z
dc.date.issued2020-04-23
dc.description.abstractAntiarrhythmic drugs are often the last resort for recurrent ventricular tachycardia refractory to catheter ablation in implantable cardioverter-defibrillator carriers. Amiodarone, alone or combined with mexiletine, is usually but not always highly effective, and its use is usually limited by systemic adverse effects. We present the case of a 62 years old man with recurrent ICD shocks due to a VT refractory to an endo-epicardial hybrid ablation. Starting of dronedarone plus mexiletine combination showed an excellent result.
dc.identifier.doi10.1016/j.repc.2017.11.018
dc.identifier.essn2174-2049
dc.identifier.pmid32336522
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.repc.2017.11.018
dc.identifier.urihttp://hdl.handle.net/10668/15435
dc.issue.number3
dc.journal.titleRevista portuguesa de cardiologia
dc.journal.titleabbreviationRev Port Cardiol (Engl Ed)
dc.language.isoen
dc.language.isopt
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number171-173
dc.pubmedtypeCase Reports
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAblação por cateter
dc.subjectAntiarrhythmic drugs
dc.subjectArritmias ventriculares
dc.subjectCatheter ablation
dc.subjectDronedarona
dc.subjectDronedarone
dc.subjectFármacos anti-arrítmicos
dc.subjectMexiletina
dc.subjectMexiletine
dc.subjectVentricular arrhythmias
dc.subject.meshAmiodarone
dc.subject.meshAnti-Arrhythmia Agents
dc.subject.meshCatheter Ablation
dc.subject.meshDefibrillators, Implantable
dc.subject.meshDronedarone
dc.subject.meshDrug Therapy, Combination
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMexiletine
dc.subject.meshMiddle Aged
dc.subject.meshTachycardia, Ventricular
dc.subject.meshTreatment Outcome
dc.titleDramatic reduction of ventricular tachycardia burden after dronedarone plus mexiletine treatment in a patient refractory to hybrid ablation.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number39
dspace.entity.typePublication

Files